Finding winners in biotech, probably the riskiest sector
Investing Experts
Intro
This chapter explores the investment journey with Tarsus Pharmaceuticals, particularly its lead drug Xdemvi for treating demodex blepharitis. The discussion includes initial skepticism, financial performance, and strategies for navigating risks in biotechnology investments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
